Download Files:
Products Details
Product Description
– Estrogen receptor antagonist 1 is a selective estrogen receptor antagonist. Estrogen (E2) and estrogen alpha receptor (ERα) are important drivers of breast cancer development. Estrogen receptor antagonist 1 has the potential for the research of breast cancer diseases (extracted from patent WO2021249533A1, compound 4)[1].
Web ID
– HY-144137
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C28H33F4N5
References
– [1]Zhang Yan, et al. Estrogen receptor modulator compounds and their uses. Patent WO2021249533A1.
CAS Number
– 2751609-45-5
Molecular Weight
– 515.59
SMILES
– FCCCN(C1)CC2(CC2)[C@@H]1NC3=CN=C([C@]4([H])C5=C(C[C@H](N4CC(F)(F)F)C)C6=CC=CC=C6N5)C=C3
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Estrogen Receptor/ERR
Pathway
– Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
